Find News

Filter articles

Showing 1 to 10 of 1749 results

Texas universities sue J&J subsidiary over biodegradable fibres


A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

Eli Lilly refused injunction against Teva, Actavis and Mylan


The English High Court has refused to grant Eli Lilly an injunction which would have stopped Teva, Actavis and Mylan marketing a generic version of its drug Cialis (tadalafil).

Federal Circuit approves PTAB victory for Bass


NPS Pharmaceuticals suffered a knock-back yesterday, when the US Court of Appeals for the Federal Circuit affirmed a decision which found that claims covering a patent owned by NPS were unpatentable. 

Bayer collaborates with Loxo Oncology on cancer medicine


Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion.

Janssen drops biosimilar suit against Samsung


Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis.

Excision Bio licenses CRISPR technology from UC Berkeley


Excision BioTherapeutics has become the first company to secure exclusive licences from the University of California, Berkeley for “newly discovered” CRISPR gene editors. 

Reasonable foresight required for second medical use infringement: Dutch Supreme Court


Swiss-type second medical use patents can be infringed if a generic producer could have reasonably foreseen that its product would be used intentionally for the claimed use, according to the Supreme Court of the Netherlands.

Federal Circuit reverses its earlier ruling in Life Technologies v Promega


The US Court of Appeals for the Federal Circuit has reversed its findings in Life Technologies v Promega, nine months after the US Supreme Court limited overseas patent infringement. 

Brazil launches system for accessing genetic heritage


The National System for the Management of Genetic Heritage (SisGen) has been officially launched in Brazil.

Five testimonies from the Allergan-tribe patent hearing


On November 7, the House Judiciary Committee’s subcommittee on IP took part in the “Sovereign Immunity and the Intellectual Property System” hearing.

Showing 1 to 10 of 1749 results